Home | Sitemap | Contact Us     Search Ranbaxy for  
  Quick Links
 
 
   
   
 
    
 
     
 
   
 
 


Home
Investor Relations > Financials > Balance Sheet > Ranbaxy Laboratories Limited - Consolidated (US GAAP)
 

     Balance Sheet


Untitled Document

  
CONSOLIDATED BALANCE SHEET
(All amounts in Rupees Million, unless otherwise stated)
  
As at December 31,
2006
2005
ASSETS
 
 
Current assets
 
 
Cash and cash equivalents 2,762.81
2,286.33
Restricted cash 108.18
64.79
Accounts receivable, net of allowances 15,599.43
11,237.96
Inventories 15,992.42
13,539.97
Deferred income taxes 1,091.14
1,806.51
Income taxes recoverable 1,757.31
1,608.02
Other current assets, net of allowances 3,619.99
3,416.30
Total current assets 40,931.28
33,959.88
Property, plant and equipment, net 19,698.91
17,325.11
Deferred income taxes 1,792.04
1,753.44
Investment securities 600.24
423.21
Goodwill, net
10,262.79
4,379.95
Intangible assets, net 7,852.11
1,334.19
Other assets 1,042.63
670.96
Total assets 82,180.00
59,846.74
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Borrowings from banks and financial institutions 13,600.74
13,748.02
Current portion of long term debt 3,490.11
3,142.86
Trade accounts payable 7,889.38
7,357.27
Income taxes payable 830.59
765.14
Accrued expenses 2,159.19
2,085.65
Other current liabilities 1,285.30
1,346.42
Total Current Liabilities 29,255.31
28,445.36
Long-term debt, excluding current portion 22,432.96
3,116.74
Deferred income taxes 1,697.08
1,600.33
Deferred revenue 159.48
138.96
Other liabilities 1,848.35
958.71
Total Liabilities 55,393.18
34,260.10
Minority interest
334.28
164.72
Commitments and contingencies (See Note K, L,S and V)
Stockholders' equity
Common stock, Rs. 5.00 par value,
598,000,000 equity shares authorized,
 
 
372,686,964 and 372,442,190 equity shares
 
 
issued and outstanding at December 31, 2006 and 2005 respectively 1,863.43
1,862.21
Additional paid in capital 6,735.13
6,388.29
Deferred stock-based compensation
(73.93)
Retained earnings 17,486.04
17,036.85
Accumulated other comprehensive (loss) / income 367.94
208.50
Total stockholders’ equity 26,452.54
25,421.92
Total liabilities and stockholders’ equity 82,180.00
59,846.74
The accompanying notes are an integral part of these consolidated financial statements.